Difamilast, sold under the brand name Moizerto among others, is a medication used for the treatment of atopic dermatitis. Difamilast is a non-steroidal topical phosphodiesterase 4 (PDE4) inhibitor. Difamilast was discovered and developed by Otsuka Pharmaceutical.